Common use of Financial obligations of the Institution Clause in Contracts

Financial obligations of the Institution. The payments specified in Section 4(a) above shall constitute the Institution’s sole remuneration for the conduct of the Trial. In the event that Biogen has not given its prior express written approval regarding any costs or expenses, the Institution shall be responsible for all costs and expenses arising from the conduct of the Trial, including but not limited to, pharmacy fees and laboratory tests; however excluding remuneration of the Investigator and Staff members.

Financial obligations of the Institution. The payments specified in Section 4(a5(a) above shall constitute the Institution’s, Investigator’s and his/her Team’s sole remuneration for the conduct of in connection with the Trial. In the event that Biogen has not given its prior express written approval regarding any costs or expenses, the Institution shall be responsible for all costs and expenses arising from the conduct of the Trial, including but not limited to, the pharmacy fees and laboratory tests; however excluding remuneration of the Investigator and Staff members.

Financial obligations of the Institution. The payments specified in Section 4(a5(a) above shall constitute the Institution’s, Investigator’s and his/her Team’s sole remuneration for the conduct of in connection with the Trial. In the event that Biogen has not given its prior express written approval regarding any costs or expenses, the Institution shall be responsible for all costs and expenses arising from the conduct of the Trial, including but not limited to, pharmacy fees and laboratory tests; however excluding remuneration of the Investigator and Staff members.

Financial obligations of the Institution. The payments specified in Section 4(a5(a) above shall constitute the Institution’s and Investigator’s sole remuneration for the conduct of in connection with the Trial. In the event that Biogen has not given its prior express written approval regarding any costs or expenses, the Institution shall be responsible for all costs and expenses arising from the conduct of the Trial, including but not limited to, the remuneration of the Investigator and all Staff members, pharmacy fees and laboratory tests; however excluding remuneration of the Investigator and Staff members, if applicable.

Financial obligations of the Institution. The payments specified in Section 4(a5(a) above shall constitute the Institution’s sole remuneration for the conduct of the Trial. In the event that Biogen has not given its prior express written approval regarding any costs or expenses, the Institution shall be responsible for all costs and expenses arising from the conduct of the Trial, including but not limited to, pharmacy fees and laboratory tests; however however, excluding remuneration of the Investigator and Staff members.